Insider · CIK 0001693064

Gelone Steven P.

Reports to the SEC for 2 companies · KING OF PRUSSIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001693064

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-29	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−140 sh	$1.50	−$210	14,283
2023-01-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−5 sh	$1.30	−$6.5	14,423
2022-12-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−3 sh	$1.89	−$5.67	14,428
2022-12-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−4 sh	$2.02	−$8.08	14,431
2022-11-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−3 sh	$2.25	−$6.75	14,435
2022-11-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−4 sh	$2.24	−$8.957	14,438
2022-10-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−3 sh	$2.54	−$7.62	14,442
2022-10-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−4 sh	$2.72	−$10.88	14,445
2022-09-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−3 sh	$2.08	−$6.24	14,449
2022-09-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.16	−$13.937	361,311
2022-08-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.16	−$10.041	361,400
2022-08-11	Nabriva Therapeutics plcShare OptionsM Exercise/Conversion	Director	MExercise/Conversion	−93.4K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcPhantom SharesM Exercise/Conversion	Director	MExercise/Conversion	+46.7K sh	—	—	46,700
2022-08-11	Nabriva Therapeutics plcStock Appreciation RightM Exercise/Conversion	Director	MExercise/Conversion	+93.4K sh	—	—	93,400
2022-08-11	Nabriva Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−46.7K sh	—	—	0
2022-08-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.18	−$16.438	361,461
2022-07-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.18	−$10.919	361,550
2022-07-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.18	−$16.216	361,611
2022-06-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.18	−$11.102	361,700
2022-06-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.20	−$17.8	361,761
2022-05-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.21	−$12.603	361,850
2022-05-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.26	−$23.14	361,911
2022-04-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.31	−$18.91	362,000
2022-04-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.41	−$36.49	362,061
2022-03-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.42	−$25.62	362,150
2022-03-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−89 sh	$0.43	−$38.27	362,211
2022-02-28	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−61 sh	$0.45	−$27.45	362,300
2022-02-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−106 sh	$0.48	−$50.88	362,361
2022-01-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−73 sh	$0.48	−$35.04	362,467
2022-01-29	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−3,483 sh	$0.45	−$1,567.35	362,540
2022-01-28	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+46.7K sh	—	—	46,700
2022-01-28	Nabriva Therapeutics plcShare OptionsA Award	Director	AAward	+93.4K sh	—	—	93,400
2022-01-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−110 sh	$0.58	−$63.8	366,023
2021-12-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$0.60	−$37.8	366,133
2021-12-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$0.72	−$66.24	366,196
2021-11-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$0.78	−$49.14	366,288
2021-11-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$1.33	−$122.36	366,351
2021-10-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.15	−$72.45	366,443
2021-10-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$1.08	−$99.36	366,506
2021-09-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.19	−$74.97	366,598
2021-09-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−93 sh	$1.11	−$103.23	366,661
2021-08-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.06	−$66.78	366,754
2021-08-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$1.17	−$107.64	366,817
2021-07-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.10	−$69.3	366,909
2021-07-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$1.27	−$116.84	366,972
2021-06-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.35	−$85.05	367,064
2021-06-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$1.34	−$123.28	367,127
2021-05-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.38	−$86.94	367,219
2021-05-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−92 sh	$1.49	−$137.08	367,282
2021-04-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−63 sh	$1.78	−$112.14	367,374

Recent filings

Accepted (ET)
Jan 314
Gelone Steven P.0001104659-23-008855
SEC(opens sec.gov)
Jan 104
Gelone Steven P.0001104659-23-002822
SEC(opens sec.gov)
Jan 44
Gelone Steven P.0001104659-23-001005
SEC(opens sec.gov)
Dec 84
Gelone Steven P.0001104659-22-125509
SEC(opens sec.gov)
Dec 24
Gelone Steven P.0001104659-22-124183
SEC(opens sec.gov)
Nov 84
Gelone Steven P.0001104659-22-116025
SEC(opens sec.gov)
Nov 14
Gelone Steven P.0001104659-22-113568
SEC(opens sec.gov)
Oct 114
Gelone Steven P.0001104659-22-107771
SEC(opens sec.gov)
Oct 44
Gelone Steven P.0001104659-22-106051
SEC(opens sec.gov)
Sep 74
Gelone Steven P.0001104659-22-098287
SEC(opens sec.gov)
Sep 14
Gelone Steven P.0001104659-22-097113
SEC(opens sec.gov)
Aug 154
Gelone Steven P.0001104659-22-091491
SEC(opens sec.gov)
Aug 84
Gelone Steven P.0001104659-22-087404
SEC(opens sec.gov)
Aug 34
Gelone Steven P.0001104659-22-085785
SEC(opens sec.gov)
Jul 74
Gelone Steven P.0001104659-22-078025
SEC(opens sec.gov)
Jul 14
Gelone Steven P.0001104659-22-076939
SEC(opens sec.gov)
Jun 74
Gelone Steven P.0001104659-22-068984
SEC(opens sec.gov)

Companies

Address

1000 CONTINENTAL DRIVE SUITE 600

KING OF PRUSSIA, PA, 19406